CDK4 has the ability to regulate Aurora B and Cenpp expression in mouse keratinocytes

被引:1
作者
Lee, Sung Hyun [1 ]
Rodriguez, Liliana R. L. [2 ]
Majumdar, Rima [1 ]
De Marval, Paula L. Miliani [3 ]
Rodriguez-Puebla, Marcelo L. [1 ]
机构
[1] North Carolina State Univ, Dept Mol Biomed Sci, Ctr Human Hlth & Environm, Raleigh, NC 27607 USA
[2] Gen Acute Hosp, Dept Clin Anal, RA-1406 Buenos Aires, DF, Argentina
[3] Charles River Labs Inc, Morrisville, NC 27560 USA
关键词
cell-cycle; cyclin-dependent kinase 4; Aurora-B; Centromere Protein P; skin; keratinocytes; CYCLIN-DEPENDENT KINASES; CELL-CYCLE; BREAST-CANCER; IN-VITRO; TRANSCRIPTIONAL ROLE; SELECTIVE INHIBITOR; TUMOR PROMOTERS; PHASE-I; D1; SPINDLE;
D O I
10.3892/ol.2021.12993
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cyclin-dependent kinase 4 (CDK4) is a critical molecule that regulates key aspects of cell proliferation through phosphorylation of the retinoblastoma (Rb) family of proteins. In the last few years, it has been suggested that CDK4 plays alternative roles in cell proliferation and tumorigenesis. The main aim of the present study was to define a novel CDK4 function as a transcriptional regulator of genes involved in chromosome segregation, contributing to the G(2)/M phase transition. Herein, chromatin-immunoprecipitation reverse transcription-quantitative PCR assays were performed to demonstrate that CDK4 could occupy the promoter region of genes associated with chromosomal segregation, such as Aurora-B (Aurkb) and Centromere Protein P (CENP-P). Moreover, gain- and loss-of-function experiments showed that CDK4 participated in the transcriptional regulation of Aurkb and CENP-P. The finding that Aurkb may have a crucial role in chromosome bi-orientation and the spindle assembly checkpoint, and that CENP-P could be required for proper kinetochore function suggests that dysregulation of CDK4 expression induces chromosomal instability and, in some cases, cancer development.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1-pRB-E2F1 pathway
    Wang, Jing
    Zhang, Jiaxin
    Ma, Qinglong
    Zhang, Shasha
    Ma, Fengdie
    Su, Wei
    Zhang, Taotao
    Xie, Xiaodong
    Di, Cuixia
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (07) : 991 - 1005
  • [42] Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma
    D. Aguirre
    P. Boya
    D. Bellet
    S. Faivre
    F. Troalen
    J. Benard
    P. Saulnier
    S. Hopkins-Donaldson
    U. Zangemeister-Wittke
    G. Kroemer
    E. Raymond
    Apoptosis, 2004, 9 : 797 - 805
  • [43] Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models
    Sangar, Michelle L. Cook
    Genovesi, Laura A.
    Nakamoto, Madison W.
    Davis, Melissa J.
    Knobluagh, Sue E.
    Ji, Pengxiang
    Millar, Amanda
    Wainwright, Brandon J.
    Olson, James M.
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5802 - 5813
  • [44] Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma
    Aguirre, D
    Boya, P
    Bellet, D
    Faivre, S
    Troalen, F
    Benard, J
    Saulnier, P
    Hopkins-Donaldson, S
    Zangemeister-Wittke, U
    Kroemer, G
    Raymond, E
    APOPTOSIS, 2004, 9 (06) : 797 - 805
  • [45] Berberine inhibits experimental varicocele-induced cell cycle arrest via regulating cyclin D1, cdk4 and p21 proteins expression in rat testicles
    Amin, M.
    Razi, M.
    Sarrafzadeh-Rezaei, F.
    Jalali, A. Shalizar
    Najafi, G.
    ANDROLOGIA, 2018, 50 (04)
  • [46] HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer
    Zhang, Han
    Wang, Jinlu
    Li, Jingtong
    Zhou, Xiaoping
    Yin, Lei
    Wang, Yiran
    Gu, Yucui
    Niu, Xingjian
    Yang, Yue
    Ji, Hongfei
    Zhang, Qingyuan
    CANCER SCIENCE, 2021, 112 (04) : 1603 - 1613
  • [47] Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecological tumor entities
    Thorsten Heilmann
    Linda Dittmann
    Marion van Mackelenbergh
    Christoph Mundhenke
    Jörg Weimer
    Norbert Arnold
    Nicolai Maass
    Christian Schem
    Archives of Gynecology and Obstetrics, 2016, 294 : 813 - 823
  • [48] Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant gynaecological tumor entities
    Heilmann, Thorsten
    Dittmann, Linda
    van Mackelenbergh, Marion
    Mundhenke, Christoph
    Weimer, Joerg
    Arnold, Norbert
    Maass, Nicolai
    Schem, Christian
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 294 (04) : 813 - 823
  • [49] Effects of PKCa antisense RNA on human breast cancer cell proliferation and expression of cyclinD1 and CDK4
    SANG Jianli WANG YongchaoLaboratory of Cell Biology
    Chinese Science Bulletin, 1999, (12) : 1110 - 1114
  • [50] Effects of PKCa antisense RNA on human breast cancer cell proliferation and expression of cyclinD1 and CDK4
    Sang, JL
    Wang, YC
    CHINESE SCIENCE BULLETIN, 1999, 44 (12): : 1110 - 1114